Apollo, Kohlberg, Montagu pursue surgical equipment providers; Radiopharma boom aids Trilantic North America’s $945m SOFIE Biosciences exit
Barriers to entry are an attractive driver for private equity firms that already have a sizeable presence in a sector, and we discuss the influence in two healthcare markets: surgical equipment providers and radiopharmaceuticals. The post Apollo, Kohlberg, Montagu pursue surgical equipment providers; Radiopharma boom aids Trilantic North America’s $945m SOFIE Biosciences exit appeared first on PE…
We haven't written up this one. PE Hub has the full story — the link below goes straight to it.